Repository
Publications
Identification of PRMT5 as a therapeutic target in cholangiocarcinomaElurbide J, Colyn L, Latasa MU, Uriarte I, Mariani S, Lopez-Pascual A, Valbuena E, Castello-Uribe B, Arnes-Benito R, Adan-Villaescusa E, Martinez-Perez LA, Azkargorta M, Elortza F, Wu H, Krawczyk M, Schneider KM, Sangro B, Aldrighetti L, Ratti F, Casadei Gardini A, Marin JJG, Amat I, Urman JM, Arechederra M, Martinez-Chantar ML, Trautwein C, Huch M, Cubero FJ, Berasain C, G Fernandez-Barrena M, Avila MA.Gut. 2024 Sep 11:gutjnl-2024-332998. doi: 10.1136/gutjnl-2024-3329982024 |
Quality of Life and Clinical Outcomes of Endosonography-Guided Biliary Drainage in Patients with Malignant Biliary Obstruction: A Single-Center, Prospective AnalysisKrupa Ł, Smyk W, Staron R, Niemiec E, Jadwisiak A, Milkiewicz P, Żorniak M, Krawczyk MJ Palliat Med . 2024 Aug 2. doi: 10.1089/jpm.2024.00842024 |
ASO Visual Abstract: Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized Diseasevan Keulen AM, Buettner S, Olthof PB, Klümpen HJ, Erdmann JI, Izquierdo-Sanchez L, Banales JM, Goeppert B, Roessler S, Zieniewicz K, Lamarca A, Valle JW, La Casta A, Hoogwater FJH, Donadon M, Scheiter A, Marzioni M, Adeva J, Kiudeliene E, Fernández JMU, Vidili G, Mocan T, Fabris L, Krawczyk M, Folseraas T, Dopazo C, Detry O, Voiosu T, Scripcariu V, Biancaniello F, Braconi C, Macias RIR, Groot Koerkamp B.Ann Surg Oncol. 2024 Jul 12. doi: 10.1245/s10434-024-15745-42024 |
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer: a large real-life worldwide populationRimini M, Fornaro L, Rizzato M, Antonuzzo L, Rossari F, Satake T, Vandeputte H, Vivaldi C, Pressiani T, Lucchetti J, Kim J, Abidoye O, Rapposelli I, Tamberi S, Finkelmeier F, Giordano G, Nichetti F, Chon H, Braconi C, Pirrone C, Casadei-Gardini A.European Journal of Cancer. 2024. 114199. ISSN 0959-8049. https://doi.org/10.1016/j.ejca.2024.114199.2024 |
Loss of mucosal tolerance to glycoprotein 2 isoform 1 is a potential novel diagnostic biomarker for cholangiocarcinomaXia C, Krawczyk M, Di C, Krupa Ł, Kruk B, Krawczyk P, Milkiewicz P, Bao H, He X, Liu D, Fan C, Nasser A, Lopens S, Ulrich Weiss F, Frost F, Schierack P, Roggenbuck D, Liu Y.Dig Liver Dis . 2024 Jun 8:S1590-8658(24)00785-0. doi: 10.1016/j.dld.2024.05.0272024 |